Coherus Oncology, Inc. reported preliminary unaudited net revenues for Q4 and the fiscal year ending December 31, 2025, as well as cash and investments, to be presented at the J.P. Morgan Healthcare Conference on January 13, 2026. This filing emphasizes that the final results may vary significantly from these preliminary figures and have not been audited.